Clinical Trial Update: Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia

View source ↗

Summary

The clinical trial evaluating pharmacogenetically guided dosing of thiopurines in children with acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• Azathioprine (azathioprine)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Acute Lymphoblastic Leukemia | Status: COMPLETED